adjusted earnings per share was $num-one for the quarter, up num-two% compared to the same quarter last year.
we expect these investments and the impact of cycling covid vaccine revenue will be fully offset by tailwinds in our model and allow us to grow adjusted net earnings per diluted share to between $num-one and $num-two.